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The AKR mouse strain was developed by selective breeding for a high incidence of
spontaneously occurring leukemia, starting from a randombred stock in which the
incidence of the disease was low to moderate (1) . The success of the breeding program
strongly suggested that genetic factors play a role in the occurrence of the disease. This
implication was amply confirmed in studies of crosses between high- and low-leukemia
mouse strains (2) .
After the discovery by Gross (3) that the tissues of AKR mice yield a virus capable of
transmitting the disease, it soon became clear that great variations exist from one strain of
mice to another in the degree of susceptibility to the leukemogenicity of the virus. The
analysis of the complex genetic control of this phenomenon has proceeded rapidly in
recent years (4) .
A major advance in this genetic analysis came from the development of a rapid
assay for the infectivity in vitro of murine leukemia virus (MuLV), the XC cell
plaque assay (5). With this assay it could be demonstrated that AKR mice first
showed detectable levels of MuLV from the perinatal period and attained high
adult levels by 6 wk of age (6). Mice of low-leukemia strains, by contrast, were
generally devoid of detectable infectious MuLV, at least until relatively late in
life. From studies of crosses of AKR with low-leukemia, low-MuLV mouse
strains, it appears that two autosomal loci, Aku-1 and Aku-2, are the determi
nants of MuLV expression in AKR mice (7-10) . Recent studies lend support to
the idea that these prototypic "V" genes of the mouse consist of chromosomally
integrated DNA copies of the complete RNA MuLV genome (11) .
The presence of these Aku genes is strongly associated with spontaneous
tumors in segregating generations of the cross, AKR x C57L (12) . Since in this
cross no major regulatory genes exist which can suppress MuLV expression, the
presence of an Aku gene is tantamount to the presence of the virus . The studies
we now report investigated the relation between the expression of endogenous
MuLV and spontaneous leukemia in a segregating population of mice all of which
* This work was supported in part by a contract from the Virus Cancer Program of the National
Cancer Institute and by grant CA 07160-09 from the National Cancer Institute.
882
￿
THE JOURNAL OF EXPERIMENTAL MEDICINE - VOLUME 141, 1975FRANK LILLY, MARIA L. DURAN-REYNALS, AND WALLACE P, ROWE
￿
883
possess two or more copies of these Aku genes but which vary genotypically in
respect to regulatory genes capable of interfering with the expression of infectious
MuLV. The findings indicate that about half of the mice were MuLV-positive
(titer range: 10°.3-103 8) at 6 wk of age and that the level of virus expression at this
age strongly correlates with the occurrence of spontaneous leukemia much later
in life.
Materials and Methods
Experimental Design.
￿
Table I summarizes the relevant characteristics of mice of the AKR and
BALB/c parental inbred strains and their F, progeny. AKR mice show a near 100% incidence of
spontaneous leukemia, whereas BALB/c mice show only a very low and much later incidence of the
disease; thelow BALB/c level of the disease is dominant in F, hybrids. Similarly, AKR mice express
high levels of N-tropic MuLV in their tissues at 6 wk of age, whereas both BALB/c andF, mice show
at most very low levels of the virus (8, 9) . We therefore bred and observed the backcross generation,
(BALB/c x AKR) F, x AKR, for a possible correlation between MuLV expression and spontaneous
leukemia .
Leukemia incidence
MuLV expression
Aku-1 andAku-2
TABLE I
Characteristics of Parental and F, Mice of the Cross, BALB/c x AKR
Trait
￿
AKR
￿
(BALB/c x AKR) F,
￿
BALB/c
95% (8-11 mo)
￿
4% (> 1yr)
￿
low(> 1 yr)
100% (10") (6)
￿
83% (10") (9)
￿
20-60% (low titer late in life)
Aku-1/Aku-1 Aku-1/- -/-
Aku-2/Aku-2 Aku-2/- -/-
Fu-1 type
￿
Fu-1^/Fu-1"
￿
Fu-1°lFu-1°
￿
Fu-1°/Fu-1°
H-2type
￿
H-2"IH-2"
￿
H-2k/H-2d
￿
H-2d/H-2d
Both parents of this backcross generation possess the Aku-1 and Aku-2 genes, the AKR parent
being homozygous and the F, heterozygous for these genes. Since the genes are dominant, this
difference in zygosity is not a significant factor in the phenotypic differences noted between the
parents or amongthe backcross mice in relation to MuLV expression or the development ofleukemia.
On the other hand, differences among these mice at the Fu-1 and H-2 loci do influence their
phenotypes. The AKR parents are homozygous Fu-1^lFu-1" and H-2'/H-2', whereas the F, parents
are heterozygous Fu-1"lFu-1° and H-2'/H-2 . The Fu-1° allele confers relative resistance to cellular
infection with N-tropic MuLV, andthe H-2d haplotype is less favorable for viral leukemogenesis than
H-2".
Mice of the backcross generation, which should include half Fu-1"IFu-1" homozygotes and half
Fu-1"lFu-1° heterozygotes, were not typed directly for this difference, which in our standard
procedure would require challenging them with exogenous MuLV. In addition, the parental strains do
not differ at the Gpd-1 locus, which is closely linked to Fu-1 and could thus serve as a marker for it
(13) . Rather, the mice were tested individually for the presence of endogenous N-tropic MuLV in their
tissues at 6 wk of age. The major genetic factor influencing this trait in this cross is the presence or
absence of the Fu-1° allele. H-2 typing of the backcross mice was carried out directly .
Mice.
￿
Backcross progeny of (BALB/c x AKR) F, 44 and AKR as were bred and maintained at
Albert Einstein College of Medicine from parental strain mice originally obtained from TheJackson
Laboratories, Bar Harbor, Maine. Themajority ofthe backcross mice were from first litters, andthey
were housed three to four mice per cage during the observation period. Themice were observed for the
development of leukemia until the youngest were 600 days old; the experiment was then terminated,
since the disease had become a rare event among the survivors . When in extremis the mice were884
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sacrificed and atuopsied. Theleukemias were generally characterized by extreme enlargement of the
thymus often associated with pronounced enlargement of the lymph nodes and occasionally with
moderate enlargement of spleen and liver.
Virus Testing.
￿
At 6 wk of age a 1 cm terminal segment of the tail was cut off each mouse; the
segments were immediately frozen, stored at -75°C and packed in dry ice and shipped to the
National Institutes of Health for virus testing. Tail segments were rinsed with ether, ground with a
chilled mortar and pestle, and suspended in cold Eagle's basal medium containing 20% veal infusion
broth. The extracts were centrifuged, andthe supernates were tested for infectious MuLV by the XC
cell method (5) using secondary cultures of NIH Swiss mouse embryo cells. Titers are expressed as the
number of plaque-forming units per 0.4 ml of approximately 2% extract. It is probable that the
storage and shipping of the tail segments before extraction and virus testing had some effect of
lowering the observed virus titers, by comparison with what one would expect from fresh tissues
examined immediately.
H-2 Typing.
￿
Thehemagglutination method of Gorer and Mikulska (14) with minor modifications
was used to determine the H-2 type of the mice. Serum from (AKR x C57BL/6) F, mice
hyperimmunized with cells of the chemically induced BALB/c sarcoma, Meth A, detects antigens of
the H-2° haplotype, transmitted from the BALB/c grandparent to about 50% of the backcross
population studied. To onedrop of this antiserum, diluted 1 :100 and 1:400 in asaline solution of 1.8%
dextran (mol wt
￿
115,000), was added one drop of a dilute suspension of washed erythrocytes in 50%
heat-inactivated fetal calf serum in saline. The mixture was agitated and incubated at 37°C for 90
min without further agitation, and the sedimented erythrocytes were examined for agglutination by
low-power microscopy.
Results
Leukemia vs. MuLV.
￿
Of the 335 (BALB/c x AKR) F, x AKR backcross mice
for which complete MuLV and H-2 typing results were obtained, 111 (33.1%)
developed leukemia during the 19-21 mo observation period (Table 11). All but 12
of these leukemic mice showed pronounced enlargement of the thymus, and their
spleens and/or lymph nodes were usually involved as well . 31 mice (9 .3%) died of
causes other than leukemia, and 16 mice (4.8%) died of unknown causes since
they were not autopsied. Of the 111 leukemic deaths, 96 occurred among the 173
mice which had shown detectable levels of MuLV in their tissues at 6 wk of age;
15 leukemic deaths occurred among the 162 MuLV-negative animals. This
difference in leukemia incidence-55 .5% vs . 8.7%, respectively-is highly signifi-
cant (XI = 80.7 ; P << 0.001).
Among the MuLV-positive mice the virus titers observed ranged from 101-9 to
10° 3. Table III and Fig. 1 show that there was a marked correlation between
MuLV titer and leukemia incidence, the animals with the highest virus titers
showing the highest and earliest incidence of the disease. Fig. 2 depicts this
relationship graphically, illustrating the remarkable similarity of these results to
a dose-response titration pattern.
Leukemia vs. H-2 Type.
￿
The data in Tables II and III also demonstrate that
the H-2 type of the backcross mice was a further factor of importance in the
occurrence of leukemia among these mice . 71 of 166 H-2'/H-2" homozygotes
(42.8%) developed the disease, whereas only 40 of 169 H-2a/H-2d heterozygotes
(23.7%) did so. This influence of H-2 type was highly significant (XI = 13 .8 ; P <
0.001), although it was a less important factor than the level of expression of
MuLV.
Leukemia vs. Sex. Since leukemia is known to occur somewhat more
frequently among females than among males of the AKR strain, the backcross
population was also analyzed for a possible sex difference in the occurrence of theFRANK LILLY, MARIA L . DURAN-REYNALS, AND WALLACE P. ROWE
￿
885
TABLE 11
Leukemia Incidence in (BALB/c x AKR) x AKR Mice
Sex
￿
MuLV
￿
H-2 Type
￿
N
￿
Leukemic
￿
Nonleukemic
￿
Not autopsied
￿
Alive
4
￿
+
￿
kk
￿
54
￿
35 (64.8%)
￿
1
￿
5
￿
13
kd
￿
41
￿
24 (58.5%)
￿
1
￿
2
￿
14
Subtotal
￿
95
￿
59 (62.1%)
￿
2
￿
7
￿
27
kk
￿
29
￿
5 (17 .2%)
￿
1
￿
1
￿
22
kd
￿
54
￿
1 ( 1 .9%)
￿
2
￿
2
￿
49
Subtotal
￿
83
￿
6 ( 7.2%)
￿
3
￿
3
￿
71
Total
￿
178
￿
65 (36.5%)
￿
5
￿
10
￿
98
d
￿
+
￿
kk
￿
40
￿
26 (65.0%)
￿
2
￿
0
￿
12
kd
￿
38
￿
11 (28.9%)
￿
6
￿
4
￿
17
Subtotal
￿
78
￿
37 (47.4%)
￿
8
￿
4
￿
29
kk
￿
43
￿
5 (11.6%)
￿
14
￿
1
￿
23
kd
￿
36
￿
4 (11.1%)
￿
4
￿
1
￿
27
Subtotal
￿
79
￿
9 (11.3%)
￿
18
￿
2
￿
50
Total
￿
157
￿
46 (29.3%)
￿
26
￿
6
￿
79
Grand total
￿
335
￿
111 (33.1%)
￿
31
￿
16
￿
177
Statistical analysis (2 x 2 X2 method):
Leuk Nonleuk
￿
Leuk Nonleuk
￿
Leuk Nonleuk
￿
kk kd
MuLV+ 96 77 kk 71 95 4 65 113 MuLV+ 94 79
kd 40 129 8 46 111 MuLV- 72 90 MuLV- 1 15
￿
147
MuLV titer
(log,.)
X z --80.71 X2 =13.79 X2 =1 .76
￿
X2 =3.27
P<<0.001 P<0.001 P--0.18
￿
P=0.08
TABLE III
Leukemia Incidence According to 6-Wk MuLV Titer in (BALB/c x AKR) x AKR Mice
Mice developing leukemia
H-2"/H-2" H-2"/H-2° Total
3.9-3.0
￿
13/15 (87%)
￿
9/10 (90%)
￿
22/25 (88%)
2.9-2.0
￿
28/41 (68%)
￿
19/39 (49%)
￿
47/80 (59%)
1.9-1 .0
￿
14/22 (64%)
￿
2/16 (13%)
￿
16/38 (42%)
0.9-0.3
￿
6/16 (38%)
￿
5/14 (36%)
￿
11/30 (37%)
Total MuLV+
￿
61/94 (65%)
￿
35/79 (44%)
￿
96/173 (55%)
Total MuLV- ￿10/72 (14%)
￿
5/90 ( 6%)
￿
15/162( 9%)
Grand total
￿
71/166 (43%)
￿
40/169 (24%)
￿
111/335 (33%)886
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Cumulative incidences of leukemia in mice of the (BALB/c x AKR) x AKR backcross
generation. Letters refer to 6 wk MuLV titer: A, 103._ 3 .9 ; B, 102
.°_1 .9 . C, 10'.°-'.9. D, 109. a-U .9 ; E,
MuLV-negative. The number in parenthesis is the number of mice under observation in each
group.
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FIG. 2.
￿
Leukemia incidence as a function of MuLV titer in tail extracts of 6-wk old (BALB/c
x AKR) x AKR backcross mice.
disease. However, the difference observed-34.8% in females vs. 29.3% in
males-was not statistically significant.
MuLV vs. H-2 Type.
￿
Since both the presence of MuLV at 6 wk ofage and H-2
type were important factors in the occurrence of leukemia, these twofactors were
analyzed for possible interaction between themselves . 94 of 166 H-2k/H-2k
homozygotes (56.6%) and 79 of 169 H-2k/H-2d heterozygotes (46.7%) were
MuLV-positive. This difference is of only marginal statistical significance (X z
3.3; P = 0.08), and it appears that H-2 type had little influence on the early
expression of MuLV in this population.
Discussion
The experiments of Gross (3) demonstrated that a virus isolated from the tissues
of AKR mice is capable of inducing the leukemia typical of this strain . ThisFRANK LILLY, MARIA L. DURAN-REYNALS, AND WALLACE P. ROWE
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endogenous viral agent (MuLV) proved to be an RNA virus of C-type morphology
which matures by budding from cell membranes . A virus present in AKR tissues
and possessing these same properties has been detected by the XC cell assay in
vitro (6) . Our experiments demonstrate a strong association between the
presence of endogenous, XC-detectable virus and the occurrence of leukemia .
This association is particularly striking in terms of the correlation observed
(Table III and Fig. 2) between the titer of the virus and the incidence of leukemia .
Such a dose-response titration of naturally occurring MuLV is unique in tumor
virus studies to date .
The capacity of AKR mice to produce infectious MuLV appears to be a
function of the dominant Aku-1 and Aku-2 genes (8, 9) which seem to consist of
chromosomally integrated DNA copies of the RNA viral genome (11) . Meier et al .
(12) demonstrated that, in a segregating cross of AKR with the Fu-1 compatible
strain C57L, the inheritance of the Aku genes, as detected by the presence of gs
antigen and infectious MuLV, was associated with the occurrence of spontaneous
lymphoma and possibly other tumors . The results of our experiment go further,
demonstrating that the presence of Aku genes does not lead to neoplasia unless
these genes are expressed in terms of mature, infectious virus.
The suppression of MuLV replication in the cross described here is largely a function of
the Fu-1° allele. This dominant allele, which is absent in AKR mice, is present in (BALB/
c x AKR) F, hybrid mice. Thus, although these two types of mice carry the Aku genes, they
differ in that the hybrids, unlike the AKR parent, are restrictive for MuLV expression and
rarely develop leukemia. Studies in vitro (9) indicate that embryo cells from AKR and
(BALB/c x AKR) F, mice exhibit a similar frequency of induction of N-tropic virus
production following treatment with 5-iododeoxyuridine . In cultures of AKR cells, which
are Fu-1"/Fu-1" homozygous, the induced virus spreads rapidly to other cells, in which it
replicates freely. However, in cell cultures from the hybrid mice, the induced virus spreads
little if at all, largely because of the presence ofthe dominant Fu-1° allele which blocks the
spread of infection (15) . This mechanism is throught to be responsible also for the low
levels or absence of MuLV in hybrids between AKR and Fu-1° mice (9), which in turn
appears to be responsible for the absence of leukemia observed here.
An additional factor resulting in suppression of infectious MuLV was observed in the
experiment described here: a maternal factor, presumably representing antiviral anti-
body . This effect was noted previously (9) with (BALB/c x AKR) x AKR mice, as well as
with other backcrosses involving AKR and Fu-1° mice, and was seen when the mother was
the virus-positive Fu-1 heterozygote . In the present study, of 44 litters of (BALB/c x
AKR) F, x AKR, 8, totalling 61 progeny, contained either no virus-positive mice or had at
most one positive mouse with only a trace (titer < 10') of MuLV; this is significantly
different from a random distribution (P << 0 .0001 by chi-square testing for heterogeneity) .
This maternal effect may have resulted in excess numbers of mice with low titers in other
litters as well. Analysis of the data with these eight litters excluded did not alter the
patterns of results.
Thus we envision two mechanisms contributing to the suppression of MuLV in
this study: resistance due to the Fu-1° allele, and the maternal resistance factor.
Both of these operate by suppressing cell-to-cell spread of virus, and there is no
reason to postulate that they inhibit viral genome functions (induction of virus or
synthesis of viral gene products) in cells expressing their endogenous viral888
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information. These considerations strongly indicate that spontaneous lymphoma.
in the AKR hybrids studied here results primarily from the consequences of
extensive viral replication and spread .
It seems worth emphasizing that the virus testing in our experiment was
carried out on tissues taken at 6 wk of age, whereas the leukemias observed
occurred much later in life. It is doubtful that virus testing of tissues taken at 6
mo of age would have produced such a clear correlation . The difference in
magnitude of MuLV expression between AKR and hybrids of AKR with mice
carrying the Fv-1° allele is much more marked in tests at 2 wk than at 6-8 wk of
age (9); also, in mice whose early viral expression is inhibited by the maternal
resistance factor, virus reaches high titers during adulthood (W. P. Rowe,
unpublished) . It thus appears that early virus expression is a critical factor in
leukemogenesis in AKR mice .
Our experiment also confirms previous studies showing that H-2 type exerts a
significant influence on the occurrence of virus-induced leukemia (16) . However,
it is clear that H-2, unlike Fu-1, has little effect on early MuLV expression . Thus
H-2 must exert its influence by a different means from Fv-1, presumably by an
effect on a defense mechanism which controls the outgrowth of transformed cells,
perhaps by an immunological mechanism. It is of interest that this effect of H-2
manifests itself in different titration curves for the viral induction of leukemia
(see Table III) . In backcross mice with high MuLV titers ( > 103), H-2 type was
not a significant factor in the occurrence of the disease, since virtually all such
mice developed it. Conversely, mice showing no detectable MuLV showed
minimal incidences of leukemia regardless of H-2 type. Among mice with
moderate MuLV levels, however, the presence of the H-29' haplotype was
associated with a markedly lower incidence of the disease by comparison with
mice homozygous for the H-2k haplotype.
Summary
Tissue extracts from 6-wk old mice of the AKR strain (H-2k) show high levels of
infectious murine leukemia virus, and these mice show a near 100% incidence of
spontaneous leukemia. In F, mice of the cross, BALB/c x AKR (H-2d/H-2k), both
the occurrence of virus and the incidence of spontaneous leukemia are suppressed
to very low values, due largely to the presence of the Fu-11' allele inherited from
the BALB/c parent. Mice of the (BALB/c x AKR) F, x AKR backcross
generation were observed for possible correlations between virus expressions at 6
wk of age, H-2 type and leukemia incidence. H-2 type showed at most a weak
influence on the occurrence of infectious virus, but there was a very strong
correlation between the level of virus expression and the occurrence of leukemia
and a strong correlation between H-2type and leukemia. In addition, there was a
highly significant nonrandom distribution of virus-negative mice among the
backcross litters, suggesting a maternal effect on virus expression .
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